Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial.
BMC Pediatrics · 2012-03-07 · Randomised trial
Abstract
BACKGROUND: There are no published studies that have compared bronchodilatory effect of inhaled budesonide/formoterol combination with budesonide/salbutamol delivered by metered dose inhaler with a spacer in acute exacerbation of asthma in children. We, therefore, compared the bronchodilatory effects of inhaled budesonide/formoterol (dose: 200 μg and 12 μg respectively) combination with budesonide (200 μg)/salbutamol (200 μg) administered by metered dose inhaler and spacer in children of 5-15 years with mild acute exacerbation of asthma [Modified Pulmonary Index Score (MPIS) between 6-8] in this double-blind, randomized controlled trial. The primary outcome was FEV1 (% predicted) in the two groups at 1, 5, 15, 30, 60 min after administration of the study drug. RESULTS: We did not observe any significant differences in the % predicted FEV1 and MPIS between formoterol and salbutamol at various time points from 1 min to 60 min post drug administration. There was significant improvement in FEV1 (% predicted) from baseline in both the groups as early as 1 min after drug administration. CONCLUSIONS: Salbutamol or formoterol delivered along with inhaled corticosteroid by metered dose inhaler with spacer in children between 5-15 years of age with mild acute exacerbation of asthma had similar bronchodilatory effects. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00900874.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Respiratory drugs · Children · Inhaled corticosteroids · Salbutamol
Related articles
- Effects of nebulized budesonide as an adjunct to standard treatment of asthma exacerbations: a randomized, double-blind, placebo-controlled trial. (Mymensingh Med J, 2014)
- Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. (Respirology, 2013)
- High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. (Int J Immunopathol Pharmacol, 2009)
- Randomized controlled trial of ipratropium bromide and salbutamol versus salbutamol alone in children with acute exacerbation of asthma. (Indian J Pediatr, 2006)
- Co-administration of salbutamol and fluticasone for emergency treatment of children with moderate acute asthma. (Pediatr Allergy Immunol, 2005)
- Acute effect of nebulized budesonide in asthmatic children. (J Investig Allergol Clin Immunol, 2005)